This deployment is part of the Ministry’s strategy to strengthen its digital capabilities in the face of evolving global cybersecurity challenges. The VPN solution provided by IT2Trust, a leading European digital security solutions provider, is pivotal in ensuring secure and efficient communication channels for the Ministry’s staff, both within
“The Ministry’s decision to work with IT2Trust reflects its commitment to adopting cutting-edge technology to protect sensitive information and maintain seamless global operations. The VPN implementation is a crucial aspect of the Ministry’s broader cybersecurity strategy seeking to ensure the highest standards of data protection and privacy.”
About IT2Trust (www.it2trust.com)
IT2Trust is the leading distributor of business critical information technology solutions in Nordic countries. IT2Trust earns this title by ensuring the right product matching for businesses and by offering competent advisory and guidance on all products from start to finish. It offers a wide range of vendor services enabling high quality-solutions. IT2Trust’s assistance covers everything from market- and competitor analyses and product positioning to marketing, technical support, and training at every level. With IT2Trust, you get a solution covering all needs, delivered by a serious and competent adviser and partner.
About
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to regain compliance with the Nasdaq continued listing standards, market conditions and the impact of the reverse stock split on the trading price of our common stock; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into
Engage with BIO-key | |
Facebook – Corporate: | https://www.facebook.com/BIOkeyInternational/ |
LinkedIn – Corporate: | https://www.linkedin.com/company/bio-key-international |
Twitter – Corporate: | @BIOkeyIntl |
Twitter – Investors: | @BIO_keyIR |
BIO_keyIR |
Investor Contacts
Catalyst IR
BKYI@catalyst-ir.com or 212-924-9800
Source:
2024 GlobeNewswire, Inc., source